Abstract
Fatal airway obstruction from ACEI angioedema has been described but effective therapy has not been established. Intubation is sometimes required for progressive airway compromise. Ecallantide is a kallikrein pathway blocker and may offer benefit in reversing ACEI induced angioedema.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have